Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-06-09

Clinical Trial Update: Correlation Between SV2A Expression in Tumour Tissue and Efficacy of Levetiracetam in Glioma Patients With Epilepsy

View source ↗

Summary

This clinical trial investigates whether SV2A expression in glioma tissue correlates with the efficacy of levetiracetam in patients with epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Epilepsy, Glioma | Status: UNKNOWN